Remove Diabetes Remove Diagnose Remove Events Remove Patient-Centered
article thumbnail

Why Identifying and Managing Giant Cell Arteritis as an Emergency Is Crucial

Physician's Weekly

Leonard Calabrese, DO, Paras Karmacharya, MD, MS, and Adam Kilian, MD, break down why giant cell arteritis (GCA) demands immediate action, explain how to confirm diagnosis quickly, and what same-day treatment options like upadacitinib (Rinvoq) mean for patient care. Video Transcript: Hi, this is Dr. Len Calabrese. Hello everyone.

article thumbnail

Causes of Brain Fog & How to Get Rid of It

AMMD

These include our physical environment, jobs, relationships, traffic, and unexpected events. I battled thyroid disease in medical school after being diagnosed with Graves’ disease. Hypothyroidism (an under-active thyroid) is the most common form of thyroid dysfunction, and 90% of hypothyroidism patients have Hashimoto’s.

IT 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guidelines or Goals in Heart Failure: A Podcast with Parag Goyal, Nicole Superville, and Matthew Shuster

GeriPal

We talk about what is heart failure, particularly HFpEF, how we treat it (including the use of sodium–glucose cotransporter-2 inhibitors (SGLT2’s), and how we should apply guidelines to individual patients, especially those with multimorbidity who are taking a lot of other medications. When I see a patient? Matthew, I get the lyrics.

article thumbnail

Cachexia and Anorexia in Serious Illness: A Podcast with Eduardo Bruera

GeriPal

Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Illness 133
article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

However, as noted in our editorial published with the donanemab trial , the modest benefits of amyloid antibodies would likely not be questioned by patients, clinicians, or payers if amyloid antibodies were low risk, inexpensive, and simple to administer. However, they are none of these. Welcome back to the GeriPal podcast, Jason.

article thumbnail

On Racism & Ageism: Ramona Rhodes, Sharon Brangman, Tim Farrell, and Nancy Lundebjerg

GeriPal

Ramona: Well, I’ve always been interested in health equity, always been interested in looking at disparities, and the disparities that I have looked at most often have been for patients at the end of their lives. The trainee said to me something like, “But I haven’t seen any geriatric patients yet.” Eric: Yes.

IT 91
article thumbnail

Redefining Alzheimer’s Disease: A Podcast with Heather Whitson, Jason Karlawish, Lon Schneider

GeriPal

In particular we spend a good deal of time talking about what this means for asymptomatic patients who may have an abnormal biomarker, which by the proposed new definition would mean they would now have Alzheimer’s disease. Alex: We have an all-star cast. Heather, welcome to the GeriPal podcast. Jason, welcome back to GeriPal.

IT 115